C07D 291/08
Condensed with carbocyclic rings or ring systems
Official title: condensed with carbocyclic rings or ring systems
C07D291/08 (Condensed with carbocyclic rings or ring systems) appears on 91 US grants and 100 published applications in this corpus.
Search patents in C07D- Granted patents
- 91
- Published applications
- 100
- Assignees
- 57
- Inventors
- 237
- Latest grant
- 17 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 4 | 0 |
| 1997 | 3 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 1 |
| 2002 | 1 | 1 |
| 2003 | 1 | 3 |
| 2004 | 0 | 1 |
| 2005 | 1 | 1 |
| 2006 | 2 | 2 |
| 2007 | 2 | 3 |
| 2008 | 0 | 5 |
| 2009 | 0 | 1 |
| 2010 | 1 | 3 |
| 2011 | 3 | 2 |
| 2012 | 1 | 4 |
| 2013 | 4 | 7 |
| 2014 | 8 | 4 |
| 2015 | 3 | 3 |
| 2016 | 0 | 8 |
| 2017 | 3 | 1 |
| 2018 | 3 | 4 |
| 2019 | 25 | 20 |
| 2020 | 4 | 8 |
| 2021 | 5 | 6 |
| 2022 | 4 | 5 |
| 2023 | 0 | 2 |
| 2024 | 2 | 1 |
| 2025 | 2 | 1 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- NRF2-activating compound17 Feb 2026US 12,552,757 B2Senju Pharmaceutical Co., Ltd.
- 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors1 Apr 2025US 12,264,137 B2Valo Health, Inc.
- Photo-coupled synergistically crosslinked hydrogel material and its composition, preparation method, use, product, and preparation kit11 Mar 2025US 12,247,089 B2Zhongshan Guanghe Medical Technology Co., Ltd
- Process and intermediates for the preparation of certain nematicidal sulfonamides13 Feb 2024US 11,897,854 B2Corteva Agriscience LLC
- 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors6 Feb 2024US 11,891,365 B2Valo Health, Inc.
- Novel compound or salt thereof, catalyst, method of preparing novel compound or salt thereof and method of preparing mannich product8 Oct 2026US 2026/0308178 A1Okinawa Institute of Science and Technology School Corporation
- Continuous-flow catalytic dehydration process for the synthesis of macrocyclic compounds16 Jul 2026US 2026/0200889 A1Indian Institute of Science Education and Research, Pune (IISER Pune)
- Solid forms comprising (5r,6s)-10,11-difluoro-12-((2-fluoro-4-iodophenyl)amino)-5,6-dihydroxy-4,5,6,7-tetrahydro-1h-spiro[benzo[b][1,5,4]oxathiazecine-3,1'-cyclopropane] 2,2-dioxide, and compositions comprising and methods of using the same9 Jul 2026US 2026/0193221 A1Pasithea Therapeutics Corp.
- Macrocyclic inhibitors of atp citrate lyase18 Sep 2025US 2025/0289793 A1Esperion Therapeutics, Inc.
- Process and intermediates for the preparation of certain nematicidal sulfonamides25 Apr 2024US 2024/0132459 A1Corteva Agriscience LLC
Most cited
By later US patents
- 3-aryl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors38US 10,112,915 B2FORMA Therapeutics, Inc. · 2018
- Phenylene alkyne matrix metalloproteinase inhibitors27US 6,849,648 B2Warner-Lambert Company · 2005
- Fused heterocyclic compounds as ion channel modulators27US 8,586,732 B2Gilead Sciences, Inc. · 2013
- Aminobenzosultam derivatives as lipoxygenase inhibitors26US 5,504,095 APfizer Inc. · 1996
- Substituted 2,2-dioxo-1,2,3-benzoxathiazines24US 4,166,177 AMerck & Co., Inc. · 1979